NasdaqGS:MMSIMedical Equipment
Merit Medical’s Expansion Push Tests Acquisition Execution And Growth Targets
Merit Medical Systems, NasdaqGS:MMSI, has launched its "Continued Growth Initiatives" Program with multi-year company-wide targets.
The company recently completed the merger with Biolife Delaware, expanding its capabilities in interventional medical products.
Merit Medical Systems also acquired the C2 CryoBalloon device, adding a new technology platform to its product portfolio.
Merit Medical Systems, trading around $77.18, comes into these new moves after a mixed stretch for shareholders...